HYPHENS PHARMA INTL LIMITED
(SGX: 1J5)

Hyphens Pharma International Limited and its subsidiaries (the "Group") is one of Singapores leading specialty pharmaceutical and consumer healthcare groups leveraging on its diverse footprint in ASEAN countries. The Group has a direct presence in five ASEAN countries, namely, Singapore, Vietnam, Malaysia, Indonesia and the Philippines, supplemented by a marketing and distribution network covering five additional jurisdictions, namely, Hong Kong, Myanmar, Brunei, Cambodia and Oman. Singapore is the Groups regional headquarters, where its strategic planning, finance, regulatory affairs, research and development, legal, business development and logistics operations are based.The Groups core business comprises the following segments: specialty pharma principals, proprietary brands, and medical hypermart and digital. Besides marketing and selling a range of specialty pharmaceutical products in selected ASEAN countries through exclusive distributorship or licensing and supply agreements with brand principals mainly from Europe and the United States, the Group also develops, markets and sells its own proprietary range of dermatological products and health supplement products. In addition, the Group operates a medical hypermart for healthcare professionals, healthcare institutions and retail pharmacies, to supply pharmaceutical products and medical supplies.

0.280 -

+0.005 (+1.82%)
Range 0.275 - 0.280   (1.82%)
Open 0.275
Previous Close 0.275
Bid Price 0.275
Bid Volume ('000) 63
Ask Price 0.285
Ask Volume ('000) 2
Volume ('000) 6.5
Value 1,808
Remark -
Delayed prices. Updated at 16 Jul 2024 15:32.
Data powered by
View All Events


Loading Chart...

Please login to view stock data and analysis